May 12 is ME/CFS Awareness Day. Fuel progress all month long—join the May Momentum campaign!

Long COVID Clinic Studies

3d-microscopic-photo-covid-19-coronavirus-scaled.jpg

The clinic in Uppsala continues the work of the OMF-Funded MultiCenter Collaborative Study on COVID to ME/CFS progression.

Home Visit Study

This study provides a unique opportunity to bring the lab directly into patient homes and provide immediate analysis of samples over an extended period of time.

This longitudinal approach without the invasive and/or PEM-induced measures will be vitally important in other patient cohorts and will decrease the study impact on patients from using more invasive and impactful measures (use of 1 peripheral vein catheter for all blood samples, limits the impact on patients).

Deep Proteome and Metabolome Profiling

Decode the molecular mechanisms underlying ME/CFS and contributing to specific symptoms with a particular emphasis of post-exertional malaise (PEM). This includes deep phenotyping of ME patients and global proteomic/metabolomics plasma profiling of ME..

Sleep Disturbance in ME/CFS

We intend to examine multiple sleep studies that have been conducted in the past two years and performed at the MGH Neurology Sleep Medicine Laboratory in well characterized patients with ME/CFS.

Autoimmunity and Autoantibodies

The aim is to investigate potential differences in adrenergic and muscarinic receptor autoantibody levels in plasma and cerebrospinal fluid samples between ME/CFS patients and healthy controls.